Skip to main content
. 2022 Jul 9;4:100076. doi: 10.1016/j.dadr.2022.100076

Table 3.

Types and frequency of adverse events reported by participants.

Number of Participants per Non-Invasive Neuromodulation Technique
rTMS (N = 286)
tDCS (N = 428)
Type of Adverse Event Active (n = 143) Sham (n = 143) Active (n = 220) Sham (n = 208)
Headaches 10 0 2 1
Discomfort at Stimulation Side 1 0 4 1
Seizure 0 1 0 0
Heaviness of the Head 0 1 0 0
Tingling 0 0 16 13
Itchiness 0 0 0 1
Mood Changes 0 0 0 1
Total Number of Adverse Events 11 2 22 17